nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ulcerative colitis—colon cancer	0.487	1	CtDrD
Hydrocortisone—ABCB1—colon cancer	0.148	1	CbGaD
Hydrocortisone—ABCG2—Irinotecan—colon cancer	0.0262	0.104	CbGbCtD
Hydrocortisone—ABCG2—Fluorouracil—colon cancer	0.0251	0.0994	CbGbCtD
Hydrocortisone—ABCG2—Vincristine—colon cancer	0.0229	0.0905	CbGbCtD
Hydrocortisone—CYP3A7—Irinotecan—colon cancer	0.0193	0.0765	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0193	0.0765	CbGbCtD
Hydrocortisone—SLCO1A2—Methotrexate—colon cancer	0.0185	0.0731	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0169	0.0668	CbGbCtD
Hydrocortisone—CYP3A7—Vincristine—colon cancer	0.0169	0.0668	CbGbCtD
Hydrocortisone—CYP3A5—Irinotecan—colon cancer	0.0145	0.0574	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—colon cancer	0.0139	0.0548	CbGbCtD
Hydrocortisone—CYP2C8—Fluorouracil—colon cancer	0.0134	0.0529	CbGbCtD
Hydrocortisone—CYP3A5—Vincristine—colon cancer	0.0127	0.0501	CbGbCtD
Hydrocortisone—ABCB1—Irinotecan—colon cancer	0.00944	0.0373	CbGbCtD
Hydrocortisone—ABCB1—Vincristine—colon cancer	0.00825	0.0326	CbGbCtD
Hydrocortisone—CYP3A4—Irinotecan—colon cancer	0.00566	0.0224	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—colon cancer	0.005	0.0198	CbGbCtD
Hydrocortisone—CYP3A4—Vincristine—colon cancer	0.00494	0.0196	CbGbCtD
Hydrocortisone—ANXA1—gall bladder—colon cancer	0.0016	0.0827	CbGeAlD
Hydrocortisone—CYP11B2—renal system—colon cancer	0.00113	0.0582	CbGeAlD
Hydrocortisone—ANXA1—embryo—colon cancer	0.00101	0.0524	CbGeAlD
Hydrocortisone—ANXA1—epithelium—colon cancer	0.000827	0.0428	CbGeAlD
Hydrocortisone—ANXA1—smooth muscle tissue—colon cancer	0.000797	0.0412	CbGeAlD
Hydrocortisone—ANXA1—renal system—colon cancer	0.000767	0.0397	CbGeAlD
Hydrocortisone—ANXA1—lymphoid tissue—colon cancer	0.000637	0.0329	CbGeAlD
Hydrocortisone—ANXA1—digestive system—colon cancer	0.000629	0.0325	CbGeAlD
Hydrocortisone—ANXA1—bone marrow—colon cancer	0.00058	0.03	CbGeAlD
Hydrocortisone—ANXA1—vagina—colon cancer	0.000555	0.0287	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—colon cancer	0.000527	0.0273	CbGeAlD
Hydrocortisone—ANXA1—liver—colon cancer	0.000469	0.0242	CbGeAlD
Hydrocortisone—CYP3A7—liver—colon cancer	0.000466	0.0241	CbGeAlD
Hydrocortisone—SLCO1A2—renal system—colon cancer	0.000426	0.022	CbGeAlD
Hydrocortisone—CYP3A7-CYP3A51P—liver—colon cancer	0.000396	0.0205	CbGeAlD
Hydrocortisone—SHBG—bone marrow—colon cancer	0.000387	0.02	CbGeAlD
Hydrocortisone—SHBG—vagina—colon cancer	0.000371	0.0192	CbGeAlD
Hydrocortisone—ANXA1—lymph node—colon cancer	0.000359	0.0186	CbGeAlD
Hydrocortisone—NR3C1—embryo—colon cancer	0.000352	0.0182	CbGeAlD
Hydrocortisone—SLCO1A2—digestive system—colon cancer	0.000349	0.0181	CbGeAlD
Hydrocortisone—ABCB1—blood vessel—colon cancer	0.000316	0.0163	CbGeAlD
Hydrocortisone—SHBG—liver—colon cancer	0.000313	0.0162	CbGeAlD
Hydrocortisone—CYP2C8—renal system—colon cancer	0.000297	0.0154	CbGeAlD
Hydrocortisone—NR3C1—epithelium—colon cancer	0.000287	0.0149	CbGeAlD
Hydrocortisone—NR3C1—smooth muscle tissue—colon cancer	0.000277	0.0143	CbGeAlD
Hydrocortisone—CYP3A5—renal system—colon cancer	0.000268	0.0139	CbGeAlD
Hydrocortisone—NR3C1—renal system—colon cancer	0.000266	0.0138	CbGeAlD
Hydrocortisone—SLCO1A2—liver—colon cancer	0.00026	0.0135	CbGeAlD
Hydrocortisone—NR3C1—lymphoid tissue—colon cancer	0.000221	0.0114	CbGeAlD
Hydrocortisone—CYP3A5—digestive system—colon cancer	0.00022	0.0114	CbGeAlD
Hydrocortisone—ABCG2—bone marrow—colon cancer	0.000219	0.0113	CbGeAlD
Hydrocortisone—NR3C1—digestive system—colon cancer	0.000218	0.0113	CbGeAlD
Hydrocortisone—CYP2C8—vagina—colon cancer	0.000215	0.0111	CbGeAlD
Hydrocortisone—ABCG2—vagina—colon cancer	0.000209	0.0108	CbGeAlD
Hydrocortisone—CYP3A4—renal system—colon cancer	0.000201	0.0104	CbGeAlD
Hydrocortisone—NR3C1—bone marrow—colon cancer	0.000201	0.0104	CbGeAlD
Hydrocortisone—CYP3A5—vagina—colon cancer	0.000194	0.0101	CbGeAlD
Hydrocortisone—NR3C1—vagina—colon cancer	0.000193	0.00998	CbGeAlD
Hydrocortisone—ABCB1—embryo—colon cancer	0.000188	0.00975	CbGeAlD
Hydrocortisone—Skin discolouration—Methotrexate—colon cancer	0.000184	0.00263	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Irinotecan—colon cancer	0.000184	0.00262	CcSEcCtD
Hydrocortisone—Myocardial infarction—Irinotecan—colon cancer	0.000182	0.00261	CcSEcCtD
Hydrocortisone—Gastroenteritis—Capecitabine—colon cancer	0.000182	0.00261	CcSEcCtD
Hydrocortisone—CYP2C8—liver—colon cancer	0.000182	0.0094	CbGeAlD
Hydrocortisone—Infestation NOS—Fluorouracil—colon cancer	0.000178	0.00255	CcSEcCtD
Hydrocortisone—Infestation—Fluorouracil—colon cancer	0.000178	0.00255	CcSEcCtD
Hydrocortisone—ABCG2—liver—colon cancer	0.000177	0.00914	CbGeAlD
Hydrocortisone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000176	0.00251	CcSEcCtD
Hydrocortisone—Myocardial infarction—Fluorouracil—colon cancer	0.000175	0.0025	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Fluorouracil—colon cancer	0.000175	0.0025	CcSEcCtD
Hydrocortisone—Increased appetite—Capecitabine—colon cancer	0.000172	0.00246	CcSEcCtD
Hydrocortisone—Inflammation—Methotrexate—colon cancer	0.000171	0.00244	CcSEcCtD
Hydrocortisone—Hallucination—Vincristine—colon cancer	0.000171	0.00244	CcSEcCtD
Hydrocortisone—Bradycardia—Irinotecan—colon cancer	0.00017	0.00243	CcSEcCtD
Hydrocortisone—Vasculitis—Methotrexate—colon cancer	0.00017	0.00243	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Vincristine—colon cancer	0.000169	0.00241	CcSEcCtD
Hydrocortisone—Haemoglobin—Irinotecan—colon cancer	0.000168	0.0024	CcSEcCtD
Hydrocortisone—Haemorrhage—Irinotecan—colon cancer	0.000167	0.00239	CcSEcCtD
Hydrocortisone—Cardiac failure—Capecitabine—colon cancer	0.000166	0.00237	CcSEcCtD
Hydrocortisone—CYP3A4—digestive system—colon cancer	0.000165	0.00855	CbGeAlD
Hydrocortisone—Lethargy—Capecitabine—colon cancer	0.000165	0.00236	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Irinotecan—colon cancer	0.000164	0.00235	CcSEcCtD
Hydrocortisone—CYP3A5—liver—colon cancer	0.000164	0.00849	CbGeAlD
Hydrocortisone—NR3C1—liver—colon cancer	0.000163	0.00842	CbGeAlD
Hydrocortisone—Osteoarthritis—Capecitabine—colon cancer	0.000162	0.00231	CcSEcCtD
Hydrocortisone—Haemoglobin—Fluorouracil—colon cancer	0.000161	0.0023	CcSEcCtD
Hydrocortisone—Haemorrhage—Fluorouracil—colon cancer	0.00016	0.00229	CcSEcCtD
Hydrocortisone—Skin exfoliation—Methotrexate—colon cancer	0.000158	0.00226	CcSEcCtD
Hydrocortisone—Irritability—Capecitabine—colon cancer	0.000154	0.00221	CcSEcCtD
Hydrocortisone—ABCB1—epithelium—colon cancer	0.000154	0.00795	CbGeAlD
Hydrocortisone—Cardiac arrest—Capecitabine—colon cancer	0.000154	0.0022	CcSEcCtD
Hydrocortisone—Mood swings—Capecitabine—colon cancer	0.000153	0.00219	CcSEcCtD
Hydrocortisone—Immune system disorder—Irinotecan—colon cancer	0.000151	0.00216	CcSEcCtD
Hydrocortisone—Mental disorder—Vincristine—colon cancer	0.00015	0.00215	CcSEcCtD
Hydrocortisone—Ecchymosis—Methotrexate—colon cancer	0.00015	0.00214	CcSEcCtD
Hydrocortisone—Arrhythmia—Irinotecan—colon cancer	0.000149	0.00214	CcSEcCtD
Hydrocortisone—Dry skin—Capecitabine—colon cancer	0.000148	0.00212	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Capecitabine—colon cancer	0.000148	0.00211	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Methotrexate—colon cancer	0.000148	0.00211	CcSEcCtD
Hydrocortisone—Hypokalaemia—Capecitabine—colon cancer	0.000147	0.0021	CcSEcCtD
Hydrocortisone—Drospirenone—PTGS2—colon cancer	0.000144	0.123	CrCbGaD
Hydrocortisone—Arrhythmia—Fluorouracil—colon cancer	0.000143	0.00204	CcSEcCtD
Hydrocortisone—ABCB1—renal system—colon cancer	0.000143	0.00738	CbGeAlD
Hydrocortisone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000143	0.00204	CcSEcCtD
Hydrocortisone—Muscular weakness—Capecitabine—colon cancer	0.000143	0.00204	CcSEcCtD
Hydrocortisone—Abdominal distension—Capecitabine—colon cancer	0.000141	0.00201	CcSEcCtD
Hydrocortisone—Megestrol acetate—ABCB1—colon cancer	0.00014	0.12	CrCbGaD
Hydrocortisone—Erythema—Fluorouracil—colon cancer	0.000139	0.00199	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Methotrexate—colon cancer	0.000139	0.00199	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Methotrexate—colon cancer	0.000138	0.00198	CcSEcCtD
Hydrocortisone—Sweating increased—Capecitabine—colon cancer	0.000136	0.00195	CcSEcCtD
Hydrocortisone—ABCG2—lymph node—colon cancer	0.000135	0.00701	CbGeAlD
Hydrocortisone—Ill-defined disorder—Irinotecan—colon cancer	0.000135	0.00193	CcSEcCtD
Hydrocortisone—Vertigo—Vincristine—colon cancer	0.000134	0.00192	CcSEcCtD
Hydrocortisone—Malaise—Irinotecan—colon cancer	0.000131	0.00188	CcSEcCtD
Hydrocortisone—Vertigo—Irinotecan—colon cancer	0.000131	0.00187	CcSEcCtD
Hydrocortisone—Syncope—Irinotecan—colon cancer	0.00013	0.00187	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Capecitabine—colon cancer	0.00013	0.00186	CcSEcCtD
Hydrocortisone—Convulsion—Vincristine—colon cancer	0.000129	0.00185	CcSEcCtD
Hydrocortisone—Hypertension—Vincristine—colon cancer	0.000129	0.00184	CcSEcCtD
Hydrocortisone—Loss of consciousness—Irinotecan—colon cancer	0.000128	0.00183	CcSEcCtD
Hydrocortisone—Myalgia—Vincristine—colon cancer	0.000127	0.00182	CcSEcCtD
Hydrocortisone—Weight increased—Capecitabine—colon cancer	0.000127	0.00182	CcSEcCtD
Hydrocortisone—Weight decreased—Capecitabine—colon cancer	0.000126	0.00181	CcSEcCtD
Hydrocortisone—Hypertension—Irinotecan—colon cancer	0.000126	0.0018	CcSEcCtD
Hydrocortisone—NR3C1—lymph node—colon cancer	0.000125	0.00646	CbGeAlD
Hydrocortisone—Infestation NOS—Capecitabine—colon cancer	0.000125	0.00178	CcSEcCtD
Hydrocortisone—Infestation—Capecitabine—colon cancer	0.000125	0.00178	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000124	0.00178	CcSEcCtD
Hydrocortisone—CYP3A4—liver—colon cancer	0.000123	0.00637	CbGeAlD
Hydrocortisone—Acute coronary syndrome—Capecitabine—colon cancer	0.000123	0.00176	CcSEcCtD
Hydrocortisone—Lethargy—Methotrexate—colon cancer	0.000123	0.00176	CcSEcCtD
Hydrocortisone—Discomfort—Irinotecan—colon cancer	0.000122	0.00175	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Capecitabine—colon cancer	0.000122	0.00175	CcSEcCtD
Hydrocortisone—Myocardial infarction—Capecitabine—colon cancer	0.000122	0.00175	CcSEcCtD
Hydrocortisone—Oedema—Vincristine—colon cancer	0.000122	0.00174	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Vincristine—colon cancer	0.000122	0.00174	CcSEcCtD
Hydrocortisone—Infection—Vincristine—colon cancer	0.000121	0.00173	CcSEcCtD
Hydrocortisone—Convulsion—Fluorouracil—colon cancer	0.000121	0.00173	CcSEcCtD
Hydrocortisone—Osteoarthritis—Methotrexate—colon cancer	0.00012	0.00172	CcSEcCtD
Hydrocortisone—Nervous system disorder—Vincristine—colon cancer	0.00012	0.00171	CcSEcCtD
Hydrocortisone—Oedema—Irinotecan—colon cancer	0.000119	0.0017	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Irinotecan—colon cancer	0.000119	0.0017	CcSEcCtD
Hydrocortisone—Myalgia—Fluorouracil—colon cancer	0.000119	0.0017	CcSEcCtD
Hydrocortisone—ABCB1—lymphoid tissue—colon cancer	0.000118	0.00613	CbGeAlD
Hydrocortisone—Infection—Irinotecan—colon cancer	0.000118	0.00169	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Vincristine—colon cancer	0.000118	0.00169	CcSEcCtD
Hydrocortisone—Discomfort—Fluorouracil—colon cancer	0.000117	0.00168	CcSEcCtD
Hydrocortisone—ABCB1—digestive system—colon cancer	0.000117	0.00605	CbGeAlD
Hydrocortisone—Shock—Irinotecan—colon cancer	0.000117	0.00167	CcSEcCtD
Hydrocortisone—Nervous system disorder—Irinotecan—colon cancer	0.000116	0.00167	CcSEcCtD
Hydrocortisone—Anorexia—Vincristine—colon cancer	0.000116	0.00166	CcSEcCtD
Hydrocortisone—Irritability—Methotrexate—colon cancer	0.000115	0.00164	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Irinotecan—colon cancer	0.000115	0.00164	CcSEcCtD
Hydrocortisone—Mood swings—Methotrexate—colon cancer	0.000114	0.00163	CcSEcCtD
Hydrocortisone—Hypotension—Vincristine—colon cancer	0.000114	0.00163	CcSEcCtD
Hydrocortisone—Bradycardia—Capecitabine—colon cancer	0.000114	0.00163	CcSEcCtD
Hydrocortisone—Oedema—Fluorouracil—colon cancer	0.000114	0.00163	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Fluorouracil—colon cancer	0.000114	0.00163	CcSEcCtD
Hydrocortisone—Anorexia—Irinotecan—colon cancer	0.000113	0.00162	CcSEcCtD
Hydrocortisone—Infection—Fluorouracil—colon cancer	0.000113	0.00162	CcSEcCtD
Hydrocortisone—Haemoglobin—Capecitabine—colon cancer	0.000112	0.00161	CcSEcCtD
Hydrocortisone—Haemorrhage—Capecitabine—colon cancer	0.000112	0.0016	CcSEcCtD
Hydrocortisone—Nervous system disorder—Fluorouracil—colon cancer	0.000112	0.00159	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000111	0.00159	CcSEcCtD
Hydrocortisone—Tachycardia—Fluorouracil—colon cancer	0.000111	0.00159	CcSEcCtD
Hydrocortisone—Hypotension—Irinotecan—colon cancer	0.000111	0.00159	CcSEcCtD
Hydrocortisone—Insomnia—Vincristine—colon cancer	0.00011	0.00158	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Capecitabine—colon cancer	0.00011	0.00157	CcSEcCtD
Hydrocortisone—Paraesthesia—Vincristine—colon cancer	0.000109	0.00157	CcSEcCtD
Hydrocortisone—Anorexia—Fluorouracil—colon cancer	0.000108	0.00155	CcSEcCtD
Hydrocortisone—ABCB1—bone marrow—colon cancer	0.000108	0.00558	CbGeAlD
Hydrocortisone—Insomnia—Irinotecan—colon cancer	0.000107	0.00154	CcSEcCtD
Hydrocortisone—Methylprednisolone—ABCB1—colon cancer	0.000107	0.0917	CrCbGaD
Hydrocortisone—Paraesthesia—Irinotecan—colon cancer	0.000107	0.00152	CcSEcCtD
Hydrocortisone—Hypotension—Fluorouracil—colon cancer	0.000106	0.00152	CcSEcCtD
Hydrocortisone—Triamcinolone—PTGS2—colon cancer	0.000106	0.0909	CrCbGaD
Hydrocortisone—Decreased appetite—Vincristine—colon cancer	0.000106	0.00152	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Vincristine—colon cancer	0.000105	0.00151	CcSEcCtD
Hydrocortisone—Fatigue—Vincristine—colon cancer	0.000105	0.0015	CcSEcCtD
Hydrocortisone—Eye disorder—Capecitabine—colon cancer	0.000105	0.00149	CcSEcCtD
Hydrocortisone—Dyspepsia—Irinotecan—colon cancer	0.000105	0.00149	CcSEcCtD
Hydrocortisone—Pain—Vincristine—colon cancer	0.000104	0.00149	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000104	0.00148	CcSEcCtD
Hydrocortisone—ABCB1—vagina—colon cancer	0.000103	0.00534	CbGeAlD
Hydrocortisone—Decreased appetite—Irinotecan—colon cancer	0.000103	0.00148	CcSEcCtD
Hydrocortisone—Insomnia—Fluorouracil—colon cancer	0.000103	0.00147	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000103	0.00147	CcSEcCtD
Hydrocortisone—Fatigue—Irinotecan—colon cancer	0.000102	0.00146	CcSEcCtD
Hydrocortisone—Paraesthesia—Fluorouracil—colon cancer	0.000102	0.00146	CcSEcCtD
Hydrocortisone—Pancreatitis—Methotrexate—colon cancer	0.000102	0.00146	CcSEcCtD
Hydrocortisone—Pain—Irinotecan—colon cancer	0.000102	0.00145	CcSEcCtD
Hydrocortisone—Immune system disorder—Capecitabine—colon cancer	0.000101	0.00144	CcSEcCtD
Hydrocortisone—Dyspepsia—Fluorouracil—colon cancer	0.0001	0.00143	CcSEcCtD
Hydrocortisone—Arrhythmia—Capecitabine—colon cancer	9.99e-05	0.00143	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Vincristine—colon cancer	9.97e-05	0.00143	CcSEcCtD
Hydrocortisone—Decreased appetite—Fluorouracil—colon cancer	9.89e-05	0.00141	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Fluorouracil—colon cancer	9.82e-05	0.0014	CcSEcCtD
Hydrocortisone—Mental disorder—Capecitabine—colon cancer	9.8e-05	0.0014	CcSEcCtD
Hydrocortisone—Feeling abnormal—Irinotecan—colon cancer	9.78e-05	0.0014	CcSEcCtD
Hydrocortisone—Malnutrition—Capecitabine—colon cancer	9.74e-05	0.00139	CcSEcCtD
Hydrocortisone—Erythema—Capecitabine—colon cancer	9.74e-05	0.00139	CcSEcCtD
Hydrocortisone—Pain—Fluorouracil—colon cancer	9.72e-05	0.00139	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Irinotecan—colon cancer	9.71e-05	0.00139	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Methotrexate—colon cancer	9.67e-05	0.00138	CcSEcCtD
Hydrocortisone—Abdominal pain—Vincristine—colon cancer	9.64e-05	0.00138	CcSEcCtD
Hydrocortisone—Body temperature increased—Vincristine—colon cancer	9.64e-05	0.00138	CcSEcCtD
Hydrocortisone—Abdominal pain—Irinotecan—colon cancer	9.39e-05	0.00134	CcSEcCtD
Hydrocortisone—Body temperature increased—Irinotecan—colon cancer	9.39e-05	0.00134	CcSEcCtD
Hydrocortisone—Feeling abnormal—Fluorouracil—colon cancer	9.37e-05	0.00134	CcSEcCtD
Hydrocortisone—Infestation—Methotrexate—colon cancer	9.28e-05	0.00133	CcSEcCtD
Hydrocortisone—Infestation NOS—Methotrexate—colon cancer	9.28e-05	0.00133	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Capecitabine—colon cancer	9.03e-05	0.00129	CcSEcCtD
Hydrocortisone—Urticaria—Fluorouracil—colon cancer	9.03e-05	0.00129	CcSEcCtD
Hydrocortisone—Body temperature increased—Fluorouracil—colon cancer	8.99e-05	0.00129	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vincristine—colon cancer	8.98e-05	0.00128	CcSEcCtD
Hydrocortisone—Malaise—Capecitabine—colon cancer	8.78e-05	0.00126	CcSEcCtD
Hydrocortisone—Vertigo—Capecitabine—colon cancer	8.75e-05	0.00125	CcSEcCtD
Hydrocortisone—Hypersensitivity—Irinotecan—colon cancer	8.75e-05	0.00125	CcSEcCtD
Hydrocortisone—Asthenia—Vincristine—colon cancer	8.75e-05	0.00125	CcSEcCtD
Hydrocortisone—Syncope—Capecitabine—colon cancer	8.73e-05	0.00125	CcSEcCtD
Hydrocortisone—ABCB1—liver—colon cancer	8.71e-05	0.00451	CbGeAlD
Hydrocortisone—Betamethasone—PTGS2—colon cancer	8.7e-05	0.0745	CrCbGaD
Hydrocortisone—Spironolactone—ABCB1—colon cancer	8.69e-05	0.0744	CrCbGaD
Hydrocortisone—Loss of consciousness—Capecitabine—colon cancer	8.56e-05	0.00122	CcSEcCtD
Hydrocortisone—Asthenia—Irinotecan—colon cancer	8.52e-05	0.00122	CcSEcCtD
Hydrocortisone—Hypertension—Capecitabine—colon cancer	8.41e-05	0.0012	CcSEcCtD
Hydrocortisone—Hypersensitivity—Fluorouracil—colon cancer	8.38e-05	0.0012	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—colon cancer	8.37e-05	0.0012	CcSEcCtD
Hydrocortisone—Diarrhoea—Vincristine—colon cancer	8.34e-05	0.00119	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—colon cancer	8.33e-05	0.00119	CcSEcCtD
Hydrocortisone—Myalgia—Capecitabine—colon cancer	8.29e-05	0.00119	CcSEcCtD
Hydrocortisone—Anxiety—Capecitabine—colon cancer	8.26e-05	0.00118	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	8.23e-05	0.00118	CcSEcCtD
Hydrocortisone—Discomfort—Capecitabine—colon cancer	8.19e-05	0.00117	CcSEcCtD
Hydrocortisone—Prednisone—ABCB1—colon cancer	8.19e-05	0.0701	CrCbGaD
Hydrocortisone—Diarrhoea—Irinotecan—colon cancer	8.12e-05	0.00116	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—LGR5—colon cancer	8.08e-05	0.00363	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—BAX—colon cancer	8.08e-05	0.00363	CbGpPWpGaD
Hydrocortisone—Norethindrone—ABCB1—colon cancer	8.07e-05	0.0691	CrCbGaD
Hydrocortisone—Dizziness—Vincristine—colon cancer	8.06e-05	0.00115	CcSEcCtD
Hydrocortisone—Pruritus—Fluorouracil—colon cancer	8.05e-05	0.00115	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—MYC—colon cancer	8.01e-05	0.0036	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TGFB1—colon cancer	7.99e-05	0.00359	CbGpPWpGaD
Hydrocortisone—Oedema—Capecitabine—colon cancer	7.95e-05	0.00114	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CASP3—colon cancer	7.92e-05	0.00355	CbGpPWpGaD
Hydrocortisone—Infection—Capecitabine—colon cancer	7.89e-05	0.00113	CcSEcCtD
Hydrocortisone—Dizziness—Irinotecan—colon cancer	7.85e-05	0.00112	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—EGFR—colon cancer	7.83e-05	0.00352	CbGpPWpGaD
Hydrocortisone—Shock—Capecitabine—colon cancer	7.82e-05	0.00112	CcSEcCtD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	7.81e-05	0.00351	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Capecitabine—colon cancer	7.79e-05	0.00111	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—colon cancer	7.78e-05	0.00111	CcSEcCtD
Hydrocortisone—Diarrhoea—Fluorouracil—colon cancer	7.78e-05	0.00111	CcSEcCtD
Hydrocortisone—Tachycardia—Capecitabine—colon cancer	7.76e-05	0.00111	CcSEcCtD
Hydrocortisone—Vomiting—Vincristine—colon cancer	7.75e-05	0.00111	CcSEcCtD
Hydrocortisone—Skin disorder—Capecitabine—colon cancer	7.72e-05	0.0011	CcSEcCtD
Hydrocortisone—Rash—Vincristine—colon cancer	7.69e-05	0.0011	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Capecitabine—colon cancer	7.68e-05	0.0011	CcSEcCtD
Hydrocortisone—Dermatitis—Vincristine—colon cancer	7.68e-05	0.0011	CcSEcCtD
Hydrocortisone—Headache—Vincristine—colon cancer	7.64e-05	0.00109	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—colon cancer	7.63e-05	0.00343	CbGpPWpGaD
Hydrocortisone—Anorexia—Capecitabine—colon cancer	7.57e-05	0.00108	CcSEcCtD
Hydrocortisone—Vomiting—Irinotecan—colon cancer	7.55e-05	0.00108	CcSEcCtD
Hydrocortisone—Prednisolone—ABCB1—colon cancer	7.55e-05	0.0647	CrCbGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—EP300—colon cancer	7.55e-05	0.00339	CbGpPWpGaD
Hydrocortisone—Immune system disorder—Methotrexate—colon cancer	7.52e-05	0.00108	CcSEcCtD
Hydrocortisone—Dizziness—Fluorouracil—colon cancer	7.52e-05	0.00108	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	7.52e-05	0.00337	CbGpPWpGaD
Hydrocortisone—Rash—Irinotecan—colon cancer	7.49e-05	0.00107	CcSEcCtD
Hydrocortisone—Dermatitis—Irinotecan—colon cancer	7.48e-05	0.00107	CcSEcCtD
Hydrocortisone—Headache—Irinotecan—colon cancer	7.44e-05	0.00106	CcSEcCtD
Hydrocortisone—Hypotension—Capecitabine—colon cancer	7.43e-05	0.00106	CcSEcCtD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	7.4e-05	0.00332	CbGpPWpGaD
Hydrocortisone—Betamethasone—ABCB1—colon cancer	7.39e-05	0.0633	CrCbGaD
Hydrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	7.35e-05	0.0033	CbGpPWpGaD
Hydrocortisone—Mental disorder—Methotrexate—colon cancer	7.29e-05	0.00104	CcSEcCtD
Hydrocortisone—Malnutrition—Methotrexate—colon cancer	7.25e-05	0.00104	CcSEcCtD
Hydrocortisone—Erythema—Methotrexate—colon cancer	7.25e-05	0.00104	CcSEcCtD
Hydrocortisone—Nausea—Vincristine—colon cancer	7.24e-05	0.00104	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Capecitabine—colon cancer	7.24e-05	0.00104	CcSEcCtD
Hydrocortisone—Vomiting—Fluorouracil—colon cancer	7.23e-05	0.00103	CcSEcCtD
Hydrocortisone—Insomnia—Capecitabine—colon cancer	7.19e-05	0.00103	CcSEcCtD
Hydrocortisone—Rash—Fluorouracil—colon cancer	7.17e-05	0.00103	CcSEcCtD
Hydrocortisone—Dermatitis—Fluorouracil—colon cancer	7.16e-05	0.00102	CcSEcCtD
Hydrocortisone—NR3C1—Endoderm Differentiation—APC—colon cancer	7.15e-05	0.00321	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	7.15e-05	0.00321	CbGpPWpGaD
Hydrocortisone—Paraesthesia—Capecitabine—colon cancer	7.14e-05	0.00102	CcSEcCtD
Hydrocortisone—Headache—Fluorouracil—colon cancer	7.12e-05	0.00102	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—ODC1—colon cancer	7.1e-05	0.00318	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CHST5—colon cancer	7.1e-05	0.00318	CbGpPWpGaD
Hydrocortisone—Nausea—Irinotecan—colon cancer	7.05e-05	0.00101	CcSEcCtD
Hydrocortisone—Dyspepsia—Capecitabine—colon cancer	7e-05	0.001	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.98e-05	0.00313	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Capecitabine—colon cancer	6.91e-05	0.000988	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Capecitabine—colon cancer	6.86e-05	0.000981	CcSEcCtD
Hydrocortisone—Fatigue—Capecitabine—colon cancer	6.85e-05	0.00098	CcSEcCtD
Hydrocortisone—Pain—Capecitabine—colon cancer	6.8e-05	0.000972	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.79e-05	0.00305	CbGpPWpGaD
Hydrocortisone—Nausea—Fluorouracil—colon cancer	6.75e-05	0.000966	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.73e-05	0.00302	CbGpPWpGaD
Hydrocortisone—Ill-defined disorder—Methotrexate—colon cancer	6.73e-05	0.000962	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—colon cancer	6.68e-05	0.00346	CbGeAlD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—colon cancer	6.58e-05	0.00295	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—MYC—colon cancer	6.58e-05	0.00295	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.57e-05	0.00295	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Capecitabine—colon cancer	6.55e-05	0.000937	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—colon cancer	6.54e-05	0.000935	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—colon cancer	6.51e-05	0.000931	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	6.51e-05	0.00292	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Capecitabine—colon cancer	6.5e-05	0.000929	CcSEcCtD
Hydrocortisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.45e-05	0.0029	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—EGFR—colon cancer	6.43e-05	0.00289	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CA7—colon cancer	6.33e-05	0.00284	CbGpPWpGaD
Hydrocortisone—Urticaria—Capecitabine—colon cancer	6.31e-05	0.000903	CcSEcCtD
Hydrocortisone—Body temperature increased—Capecitabine—colon cancer	6.28e-05	0.000898	CcSEcCtD
Hydrocortisone—Abdominal pain—Capecitabine—colon cancer	6.28e-05	0.000898	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—colon cancer	6.28e-05	0.000898	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.25e-05	0.00281	CbGpPWpGaD
Hydrocortisone—Myalgia—Methotrexate—colon cancer	6.17e-05	0.000883	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—TGFB1—colon cancer	6.17e-05	0.00277	CbGpPWpGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	6.13e-05	0.000876	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—ODC1—colon cancer	6.12e-05	0.00274	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CHST5—colon cancer	6.12e-05	0.00274	CbGpPWpGaD
Hydrocortisone—Discomfort—Methotrexate—colon cancer	6.1e-05	0.000872	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.08e-05	0.00273	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—KRAS—colon cancer	6.08e-05	0.00273	CbGpPWpGaD
Hydrocortisone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6e-05	0.00269	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.92e-05	0.00266	CbGpPWpGaD
Hydrocortisone—Anaphylactic shock—Methotrexate—colon cancer	5.92e-05	0.000846	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—colon cancer	5.88e-05	0.00084	CcSEcCtD
Hydrocortisone—Hypersensitivity—Capecitabine—colon cancer	5.85e-05	0.000837	CcSEcCtD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	5.83e-05	0.00262	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AXIN2—colon cancer	5.81e-05	0.00261	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Methotrexate—colon cancer	5.8e-05	0.00083	CcSEcCtD
Hydrocortisone—Skin disorder—Methotrexate—colon cancer	5.75e-05	0.000822	CcSEcCtD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	5.73e-05	0.00257	CbGpPWpGaD
Hydrocortisone—Hyperhidrosis—Methotrexate—colon cancer	5.72e-05	0.000818	CcSEcCtD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.72e-05	0.00257	CbGpPWpGaD
Hydrocortisone—Asthenia—Capecitabine—colon cancer	5.7e-05	0.000815	CcSEcCtD
Hydrocortisone—Anorexia—Methotrexate—colon cancer	5.64e-05	0.000806	CcSEcCtD
Hydrocortisone—Pruritus—Capecitabine—colon cancer	5.62e-05	0.000804	CcSEcCtD
Hydrocortisone—Hypotension—Methotrexate—colon cancer	5.53e-05	0.000791	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	5.51e-05	0.00247	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.45e-05	0.00245	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Capecitabine—colon cancer	5.44e-05	0.000778	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.44e-05	0.00244	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—colon cancer	5.4e-05	0.00242	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—colon cancer	5.39e-05	0.000771	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	5.36e-05	0.00241	CbGpPWpGaD
Hydrocortisone—Insomnia—Methotrexate—colon cancer	5.35e-05	0.000765	CcSEcCtD
Hydrocortisone—NR3C1—Circadian Clock—EP300—colon cancer	5.35e-05	0.0024	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.33e-05	0.00239	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	5.32e-05	0.00239	CbGpPWpGaD
Hydrocortisone—Paraesthesia—Methotrexate—colon cancer	5.31e-05	0.00076	CcSEcCtD
Hydrocortisone—Dizziness—Capecitabine—colon cancer	5.25e-05	0.000752	CcSEcCtD
Hydrocortisone—Dyspepsia—Methotrexate—colon cancer	5.21e-05	0.000745	CcSEcCtD
Hydrocortisone—Decreased appetite—Methotrexate—colon cancer	5.14e-05	0.000735	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—colon cancer	5.11e-05	0.00073	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—colon cancer	5.1e-05	0.000729	CcSEcCtD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	5.08e-05	0.00228	CbGpPWpGaD
Hydrocortisone—Pain—Methotrexate—colon cancer	5.06e-05	0.000723	CcSEcCtD
Hydrocortisone—Dexamethasone—PTGS2—colon cancer	5.06e-05	0.0433	CrCbGaD
Hydrocortisone—Vomiting—Capecitabine—colon cancer	5.05e-05	0.000723	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.03e-05	0.00226	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CA7—colon cancer	5.01e-05	0.00225	CbGpPWpGaD
Hydrocortisone—Rash—Capecitabine—colon cancer	5.01e-05	0.000717	CcSEcCtD
Hydrocortisone—Dermatitis—Capecitabine—colon cancer	5.01e-05	0.000716	CcSEcCtD
Hydrocortisone—Headache—Capecitabine—colon cancer	4.98e-05	0.000712	CcSEcCtD
Hydrocortisone—CYP3A7—Metabolism—CA7—colon cancer	4.97e-05	0.00223	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Methotrexate—colon cancer	4.87e-05	0.000697	CcSEcCtD
Hydrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	4.86e-05	0.00218	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	4.85e-05	0.00218	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Methotrexate—colon cancer	4.84e-05	0.000692	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	4.79e-05	0.00215	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	4.75e-05	0.00213	CbGpPWpGaD
Hydrocortisone—Nausea—Capecitabine—colon cancer	4.72e-05	0.000675	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (q) signalling events—PIK3CA—colon cancer	4.7e-05	0.00211	CbGpPWpGaD
Hydrocortisone—Progesterone—ABCB1—colon cancer	4.7e-05	0.0403	CrCbGaD
Hydrocortisone—Urticaria—Methotrexate—colon cancer	4.7e-05	0.000672	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—colon cancer	4.68e-05	0.000669	CcSEcCtD
Hydrocortisone—Abdominal pain—Methotrexate—colon cancer	4.68e-05	0.000669	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.63e-05	0.00208	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	4.59e-05	0.00206	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	4.58e-05	0.00206	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—AKT1—colon cancer	4.56e-05	0.00205	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.47e-05	0.00201	CbGpPWpGaD
Hydrocortisone—Testosterone—ABCB1—colon cancer	4.45e-05	0.0381	CrCbGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.44e-05	0.00199	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—EP300—colon cancer	4.41e-05	0.00198	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Methotrexate—colon cancer	4.36e-05	0.000623	CcSEcCtD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	4.35e-05	0.00195	CbGpPWpGaD
Hydrocortisone—Dexamethasone—ABCB1—colon cancer	4.3e-05	0.0368	CrCbGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—AKT1—colon cancer	4.29e-05	0.00192	CbGpPWpGaD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	4.28e-05	0.00192	CbGpPWpGaD
Hydrocortisone—Asthenia—Methotrexate—colon cancer	4.24e-05	0.000607	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	4.21e-05	0.00189	CbGpPWpGaD
Hydrocortisone—Pruritus—Methotrexate—colon cancer	4.19e-05	0.000599	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	4.13e-05	0.00185	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—PPARG—colon cancer	4.11e-05	0.00184	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	4.09e-05	0.00183	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Methotrexate—colon cancer	4.05e-05	0.000579	CcSEcCtD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.98e-05	0.00178	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	3.93e-05	0.00176	CbGpPWpGaD
Hydrocortisone—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	3.92e-05	0.00176	CbGpPWpGaD
Hydrocortisone—Dizziness—Methotrexate—colon cancer	3.91e-05	0.000559	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	3.89e-05	0.00175	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	3.89e-05	0.00174	CbGpPWpGaD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	3.87e-05	0.00173	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—MYC—colon cancer	3.84e-05	0.00173	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	3.83e-05	0.00172	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ODC1—colon cancer	3.83e-05	0.00172	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CHST5—colon cancer	3.83e-05	0.00172	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.78e-05	0.0017	CbGpPWpGaD
Hydrocortisone—Vomiting—Methotrexate—colon cancer	3.76e-05	0.000538	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.74e-05	0.00168	CbGpPWpGaD
Hydrocortisone—Rash—Methotrexate—colon cancer	3.73e-05	0.000533	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—colon cancer	3.73e-05	0.000533	CcSEcCtD
Hydrocortisone—Headache—Methotrexate—colon cancer	3.71e-05	0.00053	CcSEcCtD
Hydrocortisone—CYP3A5—Metabolism—CA7—colon cancer	3.59e-05	0.00161	CbGpPWpGaD
Hydrocortisone—Nausea—Methotrexate—colon cancer	3.51e-05	0.000503	CcSEcCtD
Hydrocortisone—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	3.46e-05	0.00155	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	3.42e-05	0.00154	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—colon cancer	3.16e-05	0.00142	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CA7—colon cancer	3.11e-05	0.0014	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CHST5—colon cancer	3.04e-05	0.00136	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ODC1—colon cancer	3.04e-05	0.00136	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CHST5—colon cancer	3.01e-05	0.00135	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ODC1—colon cancer	3.01e-05	0.00135	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.99e-05	0.00134	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.93e-05	0.00131	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—CTNNB1—colon cancer	2.89e-05	0.0013	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—CDKN1A—colon cancer	2.83e-05	0.00127	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	2.78e-05	0.00125	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.78e-05	0.00125	CbGpPWpGaD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.75e-05	0.00123	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CA7—colon cancer	2.71e-05	0.00122	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	2.59e-05	0.00116	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.52e-05	0.00113	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	2.5e-05	0.00112	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.48e-05	0.00111	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CASP3—colon cancer	2.4e-05	0.00108	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	2.37e-05	0.00106	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.35e-05	0.00106	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	2.35e-05	0.00105	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—TGFB1—colon cancer	2.34e-05	0.00105	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	2.32e-05	0.00104	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.3e-05	0.00103	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.29e-05	0.00103	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.21e-05	0.00099	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	2.2e-05	0.000988	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CHST5—colon cancer	2.18e-05	0.000976	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ODC1—colon cancer	2.18e-05	0.000976	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.16e-05	0.000971	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.04e-05	0.000915	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.99e-05	0.000891	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.92e-05	0.00086	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CHST5—colon cancer	1.88e-05	0.000846	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ODC1—colon cancer	1.88e-05	0.000846	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ABCB1—colon cancer	1.88e-05	0.000842	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.87e-05	0.000839	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—TYMS—colon cancer	1.84e-05	0.000827	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.71e-05	0.000769	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.68e-05	0.000755	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—FGFR3—colon cancer	1.68e-05	0.000753	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CA7—colon cancer	1.67e-05	0.000749	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—HNF4A—colon cancer	1.66e-05	0.000747	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.65e-05	0.000741	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CHST5—colon cancer	1.64e-05	0.000737	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ODC1—colon cancer	1.64e-05	0.000737	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ABCB1—colon cancer	1.62e-05	0.000725	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TYMS—colon cancer	1.59e-05	0.000712	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.58e-05	0.00071	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—APC—colon cancer	1.54e-05	0.000691	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NRAS—colon cancer	1.54e-05	0.000691	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.5e-05	0.000674	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	1.5e-05	0.000673	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—BRAF—colon cancer	1.45e-05	0.00065	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.42e-05	0.000636	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—colon cancer	1.4e-05	0.00063	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—PIK3CA—colon cancer	1.34e-05	0.000602	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KRAS—colon cancer	1.33e-05	0.000595	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PPARG—colon cancer	1.3e-05	0.000586	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.28e-05	0.000573	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.25e-05	0.000559	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.22e-05	0.000548	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PIK3CA—colon cancer	1.22e-05	0.000546	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.18e-05	0.000532	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.15e-05	0.000518	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.14e-05	0.000513	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—colon cancer	1.13e-05	0.000506	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PPARG—colon cancer	1.12e-05	0.000505	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.12e-05	0.000501	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—colon cancer	1.1e-05	0.000492	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CASP3—colon cancer	1.09e-05	0.000487	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.06e-05	0.000477	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—colon cancer	1.06e-05	0.000474	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CTNNB1—colon cancer	1.05e-05	0.00047	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.04e-05	0.000465	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.03e-05	0.000463	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—colon cancer	1.03e-05	0.000461	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1A—colon cancer	1.02e-05	0.000459	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ABCB1—colon cancer	1.01e-05	0.000455	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CHST5—colon cancer	1.01e-05	0.000454	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ODC1—colon cancer	1.01e-05	0.000454	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.01e-05	0.000451	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TYMS—colon cancer	9.95e-06	0.000447	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—colon cancer	9.95e-06	0.000446	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EP300—colon cancer	9.72e-06	0.000436	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SRC—colon cancer	9.46e-06	0.000424	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.25e-06	0.000415	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.23e-06	0.000414	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—colon cancer	9.21e-06	0.000413	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—colon cancer	9.1e-06	0.000408	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.05e-06	0.000406	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—colon cancer	8.84e-06	0.000397	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	8.55e-06	0.000384	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.55e-06	0.000384	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—EP300—colon cancer	8.54e-06	0.000383	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—colon cancer	8.47e-06	0.00038	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TGFB1—colon cancer	8.45e-06	0.000379	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—colon cancer	8.29e-06	0.000372	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ABCB1—colon cancer	8.02e-06	0.00036	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ABCB1—colon cancer	7.95e-06	0.000357	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TYMS—colon cancer	7.88e-06	0.000354	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	7.85e-06	0.000352	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—colon cancer	7.83e-06	0.000351	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TYMS—colon cancer	7.81e-06	0.000351	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.78e-06	0.000349	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.66e-06	0.000344	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.6e-06	0.000341	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—EP300—colon cancer	7.36e-06	0.00033	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARG—colon cancer	7.22e-06	0.000324	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CA—colon cancer	7.19e-06	0.000323	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARG—colon cancer	7.05e-06	0.000316	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—colon cancer	6.96e-06	0.000312	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—colon cancer	6.65e-06	0.000299	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.42e-06	0.000288	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CA—colon cancer	6.31e-06	0.000283	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.12e-06	0.000275	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—colon cancer	5.88e-06	0.000264	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ABCB1—colon cancer	5.75e-06	0.000258	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TYMS—colon cancer	5.65e-06	0.000253	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARG—colon cancer	5.58e-06	0.000251	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—colon cancer	5.55e-06	0.000249	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARG—colon cancer	5.53e-06	0.000248	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CA—colon cancer	5.44e-06	0.000244	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—colon cancer	5.16e-06	0.000231	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.09e-06	0.000228	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ABCB1—colon cancer	4.98e-06	0.000223	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TYMS—colon cancer	4.89e-06	0.000219	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—EP300—colon cancer	4.61e-06	0.000207	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—colon cancer	4.44e-06	0.000199	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—colon cancer	4.39e-06	0.000197	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—colon cancer	4.35e-06	0.000195	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TYMS—colon cancer	4.26e-06	0.000191	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—colon cancer	4.12e-06	0.000185	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARG—colon cancer	4e-06	0.000179	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.76e-06	0.000169	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—EP300—colon cancer	3.65e-06	0.000164	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—EP300—colon cancer	3.62e-06	0.000162	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARG—colon cancer	3.46e-06	0.000155	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CA—colon cancer	3.41e-06	0.000153	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—colon cancer	3.15e-06	0.000141	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARG—colon cancer	3.02e-06	0.000135	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—colon cancer	2.86e-06	0.000128	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—colon cancer	2.79e-06	0.000125	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—colon cancer	2.72e-06	0.000122	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CA—colon cancer	2.7e-06	0.000121	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CA—colon cancer	2.68e-06	0.00012	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ABCB1—colon cancer	2.67e-06	0.00012	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TYMS—colon cancer	2.62e-06	0.000118	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—EP300—colon cancer	2.62e-06	0.000117	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—colon cancer	2.37e-06	0.000107	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—EP300—colon cancer	2.27e-06	0.000102	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—colon cancer	2.21e-06	9.9e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—colon cancer	2.19e-06	9.82e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—EP300—colon cancer	1.97e-06	8.86e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CA—colon cancer	1.94e-06	8.69e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARG—colon cancer	1.86e-06	8.34e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CA—colon cancer	1.68e-06	7.52e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—colon cancer	1.58e-06	7.1e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—colon cancer	1.46e-06	6.56e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CA—colon cancer	1.46e-06	6.56e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—colon cancer	1.37e-06	6.15e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—EP300—colon cancer	1.22e-06	5.46e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—colon cancer	1.19e-06	5.35e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CA—colon cancer	9e-07	4.04e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—colon cancer	7.35e-07	3.3e-05	CbGpPWpGaD
